DelBello draws added scrutiny for undisclosed funds
University of Cincinnati researcher Melissa DelBello is getting some added scrutiny after finding herself in Senator Charles Grassley's crosshairs. Grassley (R-IA) chastised the researcher for failing to disclose large sums of money she received from AstraZeneca a year after completing a study of Seroquel for bipolar disease. Grassley also criticized AstraZeneca's undisclosed financial ties to a company DelBello formed. DelBello will now be required to review all the money she has received from AstraZeneca in the last decade and will review all her financial ties to outside companies.
- check out the report in the Cincinnati Enquirer
Related Articles:
Seroquel researcher got cash from AZ. Fund report
Arms twisted, pharma promises disclosure. Disclosure report
Senate investigates pharma influence on CME. Senate report
Comments
Post new comment
Paid Research Reports
- RNA therapy: the next big thing after monoclonal antibodies?
- Biotech M&A Strategies: Deal assessments, trends and future prospects
- The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor t
- Sales Force Effectiveness


